Our top pick for
PAE Incorporated is a specialty business services business based in the US. PAE Incorporated shares (PAE) are listed on the NASDAQ and all prices are listed in US Dollars. PAE Incorporated employs 20,000 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$5.89|
|52-week range||$5.62 - $10.20|
|50-day moving average||$6.11|
|200-day moving average||$7.96|
|Wall St. target price||$11.42|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.36|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||0.34%|
|1 month (2021-09-22)||1.90%|
|3 months (2021-07-22)||-37.34%|
|6 months (2021-04-22)||-25.25%|
|1 year (2020-10-22)||-38.00%|
|2 years (2019-10-22)||-41.68%|
|3 years (2018-10-18)||N/A|
|5 years (2016-10-18)||N/A|
Valuing PAE Incorporated stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PAE Incorporated's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PAE Incorporated's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, PAE Incorporated shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
PAE Incorporated's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $150.8 million.
The EBITDA is a measure of a PAE Incorporated's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$2.9 billion|
|Operating margin TTM||3.35%|
|Gross profit TTM||$616.5 million|
|Return on assets TTM||3.78%|
|Return on equity TTM||23.67%|
|Market capitalisation||$546.3 million|
TTM: trailing 12 months
There are currently 3.1 million PAE Incorporated shares held short by investors – that's known as PAE Incorporated's "short interest". This figure is 18.4% up from 2.6 million last month.
There are a few different ways that this level of interest in shorting PAE Incorporated shares can be evaluated.
PAE Incorporated's "short interest ratio" (SIR) is the quantity of PAE Incorporated shares currently shorted divided by the average quantity of PAE Incorporated shares traded daily (recently around 539285.5887522). PAE Incorporated's SIR currently stands at 5.69. In other words for every 100,000 PAE Incorporated shares traded daily on the market, roughly 5690 shares are currently held short.
However PAE Incorporated's short interest can also be evaluated against the total number of PAE Incorporated shares, or, against the total number of tradable PAE Incorporated shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PAE Incorporated's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 PAE Incorporated shares in existence, roughly 30 shares are currently held short) or 0.0554% of the tradable shares (for every 100,000 tradable PAE Incorporated shares, roughly 55 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against PAE Incorporated.
Find out more about how you can short PAE Incorporated stock.
We're not expecting PAE Incorporated to pay a dividend over the next 12 months.
PAE Incorporated provides operational solutions and outsourced services for the United States government, other allied governments, international organizations, and companies. The company operates through two segments, Global Mission Services and National Security Solutions. The Global Mission Services segment engages in logistics and stability operations, including lifecycle logistics operations, humanitarian, and stability operations; infrastructure management, such as mission operations support, space development and operations, and test and training ranges; and force readiness comprising the maintenance and repair of military and civilian vehicle fleets and aircraft. The National Security Solutions segment offers counter-threat solutions, such as training support and counter-terrorism solutions; information optimization services, including business process outsourcing services to government agencies, such as citizenship processing and litigation services, and systems support; and intelligence solutions comprising intelligence analysis, mission support, program management, engineering, and training solutions. PAE Incorporated was founded in 1955 and is headquartered in Falls Church, Virginia. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.